http://bio2rdf.org/drugbank_resource:DB01200_DB01267_nanopub.RAdkVTJ-xjYP4SYrJFEYZyfR4slUOd7_ntye7BWM_-M9Q#head http://bio2rdf.org/drugbank_resource:DB01200_DB01267_nanopub.RAdkVTJ-xjYP4SYrJFEYZyfR4slUOd7_ntye7BWM_-M9Q http://www.nanopub.org/nschema#hasAssertion http://bio2rdf.org/drugbank_resource:DB01200_DB01267_nanopub.RAdkVTJ-xjYP4SYrJFEYZyfR4slUOd7_ntye7BWM_-M9Q#assertion http://bio2rdf.org/drugbank_resource:DB01200_DB01267_nanopub.RAdkVTJ-xjYP4SYrJFEYZyfR4slUOd7_ntye7BWM_-M9Q http://www.nanopub.org/nschema#hasProvenance http://bio2rdf.org/drugbank_resource:DB01200_DB01267_nanopub.RAdkVTJ-xjYP4SYrJFEYZyfR4slUOd7_ntye7BWM_-M9Q#provenance http://bio2rdf.org/drugbank_resource:DB01200_DB01267_nanopub.RAdkVTJ-xjYP4SYrJFEYZyfR4slUOd7_ntye7BWM_-M9Q http://www.nanopub.org/nschema#hasPublicationInfo http://bio2rdf.org/drugbank_resource:DB01200_DB01267_nanopub.RAdkVTJ-xjYP4SYrJFEYZyfR4slUOd7_ntye7BWM_-M9Q#publicationInfo http://bio2rdf.org/drugbank_resource:DB01200_DB01267_nanopub.RAdkVTJ-xjYP4SYrJFEYZyfR4slUOd7_ntye7BWM_-M9Q http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://bio2rdf.org/drugbank_resource:DB01200_DB01267_nanopub.RAdkVTJ-xjYP4SYrJFEYZyfR4slUOd7_ntye7BWM_-M9Q#assertion http://bio2rdf.org/drugbank:DB01200 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB01200_DB01267 http://bio2rdf.org/drugbank:DB01267 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB01200_DB01267 http://bio2rdf.org/drugbank_resource:DB01200_DB01267 http://purl.org/dc/terms/identifier drugbank_resource:DB01200_DB01267 http://bio2rdf.org/drugbank_resource:DB01200_DB01267 http://purl.org/dc/terms/title DDI between Bromocriptine and Paliperidone - The atypical antipsychotic agent, paliperidone, may decrease the therapeutic effect of the anti-Parkinson's agent, bromocriptine. This interaction may be due to the dopamine antagonist properties of paliperidone. Consider an alternate antipsychotic in those with Parkinson's disease or consider using clozapine or quetiapine if an atypical antipsychotic is necessary. http://bio2rdf.org/drugbank_resource:DB01200_DB01267 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction http://bio2rdf.org/drugbank_resource:DB01200_DB01267 http://www.w3.org/2000/01/rdf-schema#label DDI between Bromocriptine and Paliperidone - The atypical antipsychotic agent, paliperidone, may decrease the therapeutic effect of the anti-Parkinson's agent, bromocriptine. This interaction may be due to the dopamine antagonist properties of paliperidone. Consider an alternate antipsychotic in those with Parkinson's disease or consider using clozapine or quetiapine if an atypical antipsychotic is necessary. [drugbank_resource:DB01200_DB01267] http://bio2rdf.org/drugbank_resource:DB01200_DB01267_nanopub.RAdkVTJ-xjYP4SYrJFEYZyfR4slUOd7_ntye7BWM_-M9Q#provenance http://bio2rdf.org/drugbank_resource:DB01200_DB01267_nanopub.RAdkVTJ-xjYP4SYrJFEYZyfR4slUOd7_ntye7BWM_-M9Q#assertion http://semanticscience.org/resource/SIO_000253 http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3 http://bio2rdf.org/drugbank_resource:DB01200_DB01267_nanopub.RAdkVTJ-xjYP4SYrJFEYZyfR4slUOd7_ntye7BWM_-M9Q#publicationInfo http://bio2rdf.org/drugbank_resource:DB01200_DB01267_nanopub.RAdkVTJ-xjYP4SYrJFEYZyfR4slUOd7_ntye7BWM_-M9Q#signature.MC0CFF_gSwhM26mX http://purl.org/nanopub/x/hasPublicKey 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 http://bio2rdf.org/drugbank_resource:DB01200_DB01267_nanopub.RAdkVTJ-xjYP4SYrJFEYZyfR4slUOd7_ntye7BWM_-M9Q#signature.MC0CFF_gSwhM26mX http://purl.org/nanopub/x/hasSignature MC0CFF/gSwhM26mXe9TsYcPlJkN1L1F8AhUAljadMgfrkzHrhH5eGWDFsTMXI7A= http://bio2rdf.org/drugbank_resource:DB01200_DB01267_nanopub.RAdkVTJ-xjYP4SYrJFEYZyfR4slUOd7_ntye7BWM_-M9Q#signature.MC0CFF_gSwhM26mX http://purl.org/nanopub/x/signedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://bio2rdf.org/drugbank_resource:DB01200_DB01267_nanopub.RAdkVTJ-xjYP4SYrJFEYZyfR4slUOd7_ntye7BWM_-M9Q http://purl.org/dc/terms/created 2018-03-30T11:13:03.301+02:00 http://bio2rdf.org/drugbank_resource:DB01200_DB01267_nanopub.RAdkVTJ-xjYP4SYrJFEYZyfR4slUOd7_ntye7BWM_-M9Q http://purl.org/dc/terms/license https://creativecommons.org/licenses/by-nc/4.0/ http://bio2rdf.org/drugbank_resource:DB01200_DB01267_nanopub.RAdkVTJ-xjYP4SYrJFEYZyfR4slUOd7_ntye7BWM_-M9Q http://purl.org/nanopub/x/hasSignatureElement http://bio2rdf.org/drugbank_resource:DB01200_DB01267_nanopub.RAdkVTJ-xjYP4SYrJFEYZyfR4slUOd7_ntye7BWM_-M9Q#signature.MC0CFF_gSwhM26mX http://bio2rdf.org/drugbank_resource:DB01200_DB01267_nanopub.RAdkVTJ-xjYP4SYrJFEYZyfR4slUOd7_ntye7BWM_-M9Q http://www.w3.org/ns/prov#wasGeneratedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#specializationOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://purl.org/dc/terms/identifier 3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#used https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasAssociatedWith https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasStartedBy http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/dc/terms/isVersionOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/pav/version eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234